Andrew J. Emmett
,


Bobbie Ann Brinegar
,


Tommy Thompson
,


Conversations

As we come upon the 10th anniversary of the Medicare Part D program, is it still living up to its promise? What can be done to improve it?

Contributors Respond

Dr. Bill Chin
,


Paul Howard, Ph.D
,


Conversations

Whether you're a patient, advocate or researcher, what are you most hopeful will emerge from the biopharmaceutical pipeline in the coming years?

Contributors Respond

Tom Frieden, MD, MPH
,


Robyn Swirling
,


Roberta DeBiasi, MD
,


Pages

Subscribe to PhRMA RSS